Clinical trial
Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial
NCT02200705 · IceCure Medical Ltd., Industry · Completed
Key facts
| NCT number | NCT02200705 |
|---|---|
| Title | Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial |
| Official title | Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial) |
| Lead sponsor | IceCure Medical Ltd., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Device |
| Interventions | Ice-Sense3TM/ ProSenseTM |
| Enrollment | 206 |
| Start date | Oct 1, 2014 |
| Primary completion | Mar 17, 2024 |
| Completion | May 26, 2024 |
| First posted | Jul 25, 2014 |
| Last update posted | Apr 30, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: